Modelling prognostic factors in advanced pancreatic cancer.
Pancreatic cancer is the fifth most common cause of cancer death. Identification of defined patient groups based on a prognostic index may improve the prediction of survival and selection of therapy. Many prognostic factors have been identified often based on retrospective, underpowered studies with...
Prif Awduron: | Stocken, D, Hassan, A, Altman, D, Billingham, L, Bramhall, SR, Johnson, P, Freemantle, N |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2008
|
Eitemau Tebyg
-
Choice of transformation for modelling non-linear continuous biomarkers
gan: Stocken Deborah D, et al.
Cyhoeddwyd: (2011-12-01) -
A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.
gan: Markham, C, et al.
Cyhoeddwyd: (2003) -
Prognostic models: a methodological framework and review of models for breast cancer.
gan: Altman, D
Cyhoeddwyd: (2009) -
Advancing Prognostication in Pancreatic Cancer: A Comprehensive Cohort Analysis
gan: Shikhar Tripathi, et al.
Cyhoeddwyd: (2024-09-01) -
Locally Advanced and Metastatic Pancreatic Cancer: Survival analysis and prognostic factors in a case series
gan: Paloma Porto Amorim, et al.
Cyhoeddwyd: (2020-01-01)